Gene · 799
Papers3,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 3,617
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Three-Dimensional Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells Promotes Matrix Metallopeptidase 13 (MMP13) Expression in Type I Collagen Hydrogels. | Int J Mol Sci | 2021 | 34948393 | PubTator, text mining | PubMed |
| Autism-Related Transcription Factors Underlying the Sex-Specific Effects of Prenatal Bisphenol A Exposure on Transcriptome-Interactome Profiles in the Offspring Prefrontal Cortex. | Int J Mol Sci | 2021 | 34947998 | PubTator, text mining | PubMed |
| The Role of Plasma Membrane Viscosity in the Response and Resistance of Cancer Cells to Oxaliplatin. | Cancers (Basel) | 2021 | 34944789 | PubTator, text mining | PubMed |
| The Neuropeptide VIP Limits Human Osteoclastogenesis: Clinical Associations with Bone Metabolism Markers in Patients with Early Arthritis. | Biomedicines | 2021 | 34944693 | PubTator, text mining | PubMed |
| Unravelling the Role of PAX2 Mutation in Human Focal Segmental Glomerulosclerosis. | Biomedicines | 2021 | 34944624 | PubTator, text mining | PubMed |
| Circulating MicroRNA Expression, Vitamin D, and Hypercortisolism as Predictors of Osteoporosis in Elderly Postmenopausal Women. | Dis Markers | 2021 | 34938374 | PubTator, text mining | PubMed |
| Amylin as a Future Obesity Treatment. | J Obes Metab Syndr | 2021 | 34929674 | PubTator, text mining | PubMed |
| Ovarian Cancer-Driven Mesothelial-to-Mesenchymal Transition is Triggered by the Endothelin-1/β-arr1 Axis. | Front Cell Dev Biol | 2021 | 34926453 | PubTator, text mining | PubMed |
| Intersection of Epigenetic and Immune Alterations: Implications for Fetal Alcohol Spectrum Disorder and Mental Health. | Front Neurosci | 2021 | 34924946 | PubTator, text mining | PubMed |
| A molybdenum oxide-based degradable nanosheet for combined chemo-photothermal therapy to improve tumor immunosuppression and suppress distant tumors and lung metastases. | J Nanobiotechnology | 2021 | 34923976 | PubTator, text mining | PubMed |
| Application of Stem Cell-Derived Extracellular Vesicles as an Innovative Theranostics in Microbial Diseases. | Front Microbiol | 2021 | 34917064 | PubTator, text mining | PubMed |
| ceRNA Networks: The Backbone Role in Neoadjuvant Chemoradiotherapy Resistance/Sensitivity of Locally Advanced Rectal Cancer. | Technol Cancer Res Treat | 2021 | 34908512 | PubTator, text mining | PubMed |
| Platinum-Induced Peripheral Neuropathy (PIPN): ROS-Related Mechanism, Therapeutic Agents, and Nanosystems. | Front Mol Biosci | 2021 | 34901160 | PubTator, text mining | PubMed |
| Alantolactone: A Natural Plant Extract as a Potential Therapeutic Agent for Cancer. | Front Pharmacol | 2021 | 34899346 | PubTator, text mining | PubMed |
| Orchestrating a heist: uptake and storage of metals by apicomplexan parasites. | Microbiology (Reading) | 2021 | 34898419 | PubTator, text mining | PubMed |
| Flavonoids: Classification, Function, and Molecular Mechanisms Involved in Bone Remodelling. | Front Endocrinol (Lausanne) | 2021 | 34887836 | PubTator, text mining | PubMed |
| Tripterygium hypoglaucum (Lévl.) Hutch and Its Main Bioactive Components: Recent Advances in Pharmacological Activity, Pharmacokinetics and Potential Toxicity. | Front Pharmacol | 2021 | 34887747 | PubTator, text mining | PubMed |
| Role of Receptors in Relation to Plaques and Tangles in Alzheimer's Disease Pathology. | Int J Mol Sci | 2021 | 34884789 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell-Derived Extracellular Vesicle: A Promising Alternative Therapy for Osteoporosis. | Int J Mol Sci | 2021 | 34884554 | PubTator, text mining | PubMed |
| SOX9: Advances in Gynecological Malignancies. | Front Oncol | 2021 | 34881182 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/799/papers?page=52